Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients

被引：27
|
作者：
Nash, Tammon [1 ]
Hoffmann, Sandra [2 ]
Butch, Suzanne [2 ]
Davenport, Robertson [2 ]
Cooling, Laura [2 ]
机构：
[1] Michigan Blood, Grand Rapids, MI USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
来源：
TRANSFUSION | 2012年 / 52卷 / 10期
关键词：
BLOOD-PRODUCTS; TRANSFUSION; TRANSMISSION; INFECTION;
D O I：
10.1111/j.1537-2995.2012.03739.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2270 / 2272
页数：3
相关论文
共 24 条
  • [1] Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia
    Luis Pinana, Jose
    Gimenez, Estela
    Dolores Gomez, Maria
    Perez, Ariadna
    Maria Gonzalez, Eva
    Vinuesa, Victor
    Carlos Hernandez-Boluda, Juan
    Montoro, Juan
    Salavert, Miguel
    Tormo, Mar
    Amat, Paula
    Moles, Paula
    Carretero, Carlos
    Balaguer-Rosello, Aitana
    Sanz, Jaime
    Sanz, Guillermo
    Solano, Carlos
    Navarro, David
    JOURNAL OF INFECTION, 2019, 78 (05) : 393 - 401
  • [2] A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
    Ljungman, Per
    Schmitt, Michael
    Marty, Francisco M.
    Maertens, Johan
    Chemaly, Roy F.
    Kartsonis, Nicholas A.
    Butterton, Joan R.
    Wan, Hong
    Teal, Valerie L.
    Sarratt, Kendra
    Murata, Yoshihiko
    Leavitt, Randi Y.
    Badshah, Cyrus
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (08) : 1525 - 1533
  • [3] Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia
    Moon, S. M.
    Sung, H.
    Kim, M. -N.
    Lee, S. -O.
    Choi, S. -H.
    Kim, Y. S.
    Woo, J. H.
    Kim, S. -H.
    TRANSPLANT INFECTIOUS DISEASE, 2012, 14 (02) : 192 - 197
  • [4] Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)-Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients
    Barron, Michelle A.
    Gao, Dexiang
    Springer, Kathryn L.
    Patterson, Julie A.
    Brunvand, Mark W.
    McSweeney, Peter A.
    Zeng, Chang
    Baron, Anna E.
    Weinberg, Adriana
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (12) : 1777 - 1783
  • [5] Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
    Servais, S.
    Dumontier, N.
    Biard, L.
    Schnepf, N.
    Resche-Rigon, M.
    de Latour, R. Peffault
    Scieux, C.
    Robin, M.
    Meunier, M.
    Xhaard, A.
    de Fontbrune, F. Sicre
    Le Goff, J.
    Socie, G.
    Simon, F.
    Mazeron, M. -C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (03) : 289.e1 - 289.e7
  • [6] Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients
    Pietersma, Floor L.
    van Dorp, Suzanne
    Minnema, Monique C.
    Kuball, Jurgen
    Meijer, Ellen
    Schuurman, Rob
    van Baarle, Debbie
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : E144 - E148
  • [7] Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients
    A B Narvios
    M de Lima
    H Shah
    B Lichtiger
    Bone Marrow Transplantation, 2005, 36 : 499 - 501
  • [8] Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients
    Narvios, AB
    de Lima, M
    Shah, H
    Lichtiger, B
    BONE MARROW TRANSPLANTATION, 2005, 36 (06) : 499 - 501
  • [9] Transfusion in CMV seronegative T-depleted allogeneic stem cell transplant recipients with CMV-unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience
    Hall, S.
    Danby, R.
    Osman, H.
    Peniket, A.
    Rocha, V.
    Craddock, C.
    Murphy, M.
    Chaganti, S.
    TRANSFUSION MEDICINE, 2015, 25 (06) : 418 - 423
  • [10] Provision of cellular blood components to CMV-seronegative patients undergoing allogeneic stem cell transplantation in the UK: survey of UK transplant centres
    Morton, S.
    Peniket, A.
    Malladi, R.
    Murphy, M. F.
    TRANSFUSION MEDICINE, 2017, 27 (06) : 444 - 450
123